Option Care shares surge on report of $5B takeover bid from McKesson and Clayton Dubilier & Rice

McKesson: McKesson Corporation is a major healthcare company specializing in pharmaceutical distribution and services, with a strategic emphasis on expanding its footprint in oncology, specialty care, and related growth areas through targeted acquisitions and partnerships. It has recently extended key distribution agreements and pursued deals to reshape its portfolio toward higher-value healthcare services. McKesson is reported to be in advanced talks with Clayton Dubilier & Rice to acquire Option Care Health. Option Care: Option Care Health is a leading independent provider of infusion and specialty pharmacy services, delivering intravenous medications and therapies to patients in home and outpatient settings across the United States. The company focuses on clinical infusion care that supports complex chronic conditions outside of hospital environments. In this development, Option Care is the target of a potential acquisition by McKesson and Clayton Dubilier & Rice. Clayton Dubilier & Rice: Clayton Dubilier & Rice is a private equity firm that actively invests in healthcare and other sectors, recently strengthening its healthcare expertise by adding operating advisers with pharmaceutical industry backgrounds. The firm pursues buyouts and strategic partnerships involving healthcare services providers. It is partnering with McKesson in nearing a potential takeover of Option Care Health. M&A Activity: McKesson continues to pursue acquisitions as part of efforts to expand in specialty healthcare and higher-growth services. Healthcare Services: Infusion therapy providers deliver medications in home and outpatient settings to support patient care for chronic conditions. Private Equity Focus: Private equity firms are engaging in healthcare services transactions alongside strategic buyers to pursue undervalued assets.